Id |
Subject |
Object |
Predicate |
Lexical cue |
T291 |
0-168 |
Sentence |
denotes |
More positive values in UMAP Components 1 or 2 captured mainly signals of change or differences in individual immune features in COVID-19 disease compared to HD and RD. |
T292 |
169-585 |
Sentence |
denotes |
UMAP Component 1 captured an immunotype (Immunotype 1) that was characterized by effector or highly activated CD4 T cells, low cTfh, some CD8 TEMRA-like activation, possibly hyperactivated CD8 T cells, and Tbet+ PB, whereas Component 2 or Immunotype 2 captured Tbetbright effector-like CD8 T cells, lacked some of the robust CD4 T cell activation but has some features of proliferating B cells (Fig. 6G and fig. S8). |
T293 |
586-622 |
Sentence |
denotes |
However, the data presented in Figs. |
T294 |
623-716 |
Sentence |
denotes |
1 to 5 also suggested a subset of patients with minimal activation of T and B cell responses. |
T295 |
717-912 |
Sentence |
denotes |
To investigate this immune signature, we identified 20 patients who had responses more similar to HD and RD for five activated/responding B and T cell populations (Fig. 6J, middle, and fig. S10). |
T296 |
913-1080 |
Sentence |
denotes |
If the UMAP Components 1 and 2 captured two distinct “immunotypes” of patient responses to SARS-CoV2 infection, this group of 20 patients represent a third immunotype. |
T297 |
1081-1403 |
Sentence |
denotes |
Immunotype 3 was negatively associated with UMAP Components 1 and 2 and negatively associated with disease severity, suggesting that a less robust immune response during COVID-19 was associated with less severe pathology (Fig. 6K and fig. S10), despite the fact that these patients were hospitalized with COVID-19 disease. |
T298 |
1404-1514 |
Sentence |
denotes |
These data further emphasize the different ways patients can present and possibly succumb to COVID-19 disease. |
T299 |
1515-1624 |
Sentence |
denotes |
These patterns may be related to pre-existing conditions in combination with immune response characteristics. |
T300 |
1625-1746 |
Sentence |
denotes |
It is likely that additional immune features, such as comprehensive serum cytokine measurements, will improve this model. |
T301 |
1747-1980 |
Sentence |
denotes |
Nevertheless, the current computational approach integrating deep immune profiling with disease severity trajectory and other clinical information revealed distinct patient immunotypes linked to distinct clinical outcomes (fig. S11). |